Ads
related to: thalassemia- About Thalassemia
Find more information on
thalassemia & how to manage.
- Managing Thalassemia
There's hope for managing the
symptoms & complications.
- Thalassemia Support
Connect with a Clinical Nurse
Educator for support.
- Sign Up
Take a step forward. Sign up
for thalassemia updates.
- Healthcare Professionals
Please visit this website if
you are a healthcare professional.
- Resources
Find tools to help you get the most
out of your medical appointments.
- About Thalassemia
Search results
Is It Too Late to Buy Vertex Pharmaceuticals Stock?
Motley Fool via Yahoo Finance· 1 day agoEarlier this year, the company's gene editing therapy, Casgevy, obtained approval from regulators to treat transfusion-dependent beta thalassemia. Prior...
India urgently needs stem cell donors to fight blood disorders, say experts
Investing.com· 16 hours agoNew Delhi, May 27 (IANS) India is urgently in need of stem cell donors to fight blood cancer that...
3 Reasons to Buy CRISPR Therapeutics Stock Like There's No Tomorrow
Motley Fool via Yahoo Finance· 1 day agoCasgevy is about to start ramping up CRISPR's first commercialized product, a gene therapy called...
Is CRISPR Therapeutics a Millionaire Maker?
Motley Fool via Yahoo Finance· 5 days agoCasgevy, the biotech's first medicine to be approved for sale, is a gene therapy that treats -- or effectively cures -- a pair of hereditary blood...
3 High-Flying Stocks That Could Soar Even More
Motley Fool via Yahoo Finance· 2 days agoBut it has been expanding its horizons. Its latest regulator-approved treatment is for Casgevy, a gene-editing therapy that can provide a functional cure...
Bull Market Buys: 2 Growth Stocks to Own for the Long Run
Motley Fool via Yahoo Finance· 5 days agoImages. 1. CRISPR Therapeutics CRISPR Therapeutics (NASDAQ: CRSP) recently scored a big win when...
Vertex (VRTX) Outperforms Industry on Rapid Pipeline Progress
Zacks via Yahoo Finance· 6 days agoVertex and partner CRISPR Therapeutics’ CRSP one-shot gene therapy, Casgevy, was approved for two...
Bristol Myers Squibb Announces 10-Year Strategy to Reach More Patients in Low- and Middle-Income...
Morningstar· 5 days agoThe Company enters strategic collaboration with the Access to Oncology Medicines (ATOM) Coalition to expand access to immuno-oncology therapy Opdivo™ in select countries PRINCETON, NJ / ACCESSWIRE ...
What Basic Blood Tests Can Reveal About Your Health
Mercola· 2 days agoDr. Bryan Walsh is a naturopathic physician extensively trained in molecular biological pathways and an associate professor at the University of Western States. One of the problems is that many ...
“Cell therapies change the definition of human”
Hardwood Paroxysm· 2 days agoIn India, it was very difficult to buy books when Siddhartha Mukherjee (New Delhi, 1970) was a child. Educated at Stanford, Oxford and Harvard...
Ad
related to: thalassemia
